Insider Transactions in Q4 2025 at Stoke Therapeutics, Inc. (STOK)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 08
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
13,430
-7.61%
|
$429,760
$32.35 P/Share
|
|
Dec 08
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
3,978
-13.34%
|
$127,296
$32.11 P/Share
|
|
Dec 05
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
8,548
-4.11%
|
$264,988
$31.44 P/Share
|
|
Dec 05
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,662
-8.13%
|
$113,522
$31.34 P/Share
|
|
Dec 05
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
8,785
-13.35%
|
$272,335
$31.39 P/Share
|
|
Dec 04
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
6,453
-4.22%
|
$200,043
$31.04 P/Share
|
|
Dec 04
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,696
-3.41%
|
$52,576
$31.04 P/Share
|
|
Dec 04
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
1,018
-2.0%
|
$31,558
$31.04 P/Share
|
|
Dec 03
2025
|
Edward M. Md Kaye |
BUY
Exercise of conversion of derivative security
|
Direct |
26,250
+25.29%
|
-
|
|
Dec 03
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+28.44%
|
-
|
|
Dec 03
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+18.98%
|
-
|
|
Dec 03
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
2,292
-5.37%
|
$68,760
$30.6 P/Share
|
|
Dec 03
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
1,070
-1.03%
|
$32,100
$30.6 P/Share
|
|
Dec 03
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,014
-6.04%
|
$60,420
$30.6 P/Share
|
|
Dec 02
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
2,284
-4.83%
|
$66,236
$29.85 P/Share
|
|
Dec 02
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
1,066
-1.0%
|
$30,914
$29.85 P/Share
|
|
Dec 02
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,006
-5.37%
|
$58,174
$29.85 P/Share
|
|
Dec 01
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
12,357
+33.81%
|
-
|
|
Dec 01
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
11,981
+38.45%
|
-
|
|
Nov 24
2025
|
Adrian R. Krainer |
SELL
Open market or private sale
|
Direct |
40,472
-11.11%
|
$1,173,688
$29.72 P/Share
|
|
Nov 14
2025
|
Adrian R. Krainer |
SELL
Open market or private sale
|
Direct |
40,472
-5.13%
|
$1,052,272
$26.98 P/Share
|
|
Nov 03
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,931
-13.32%
|
$160,137
$27.03 P/Share
|
|
Oct 08
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
25,000
-33.73%
|
$750,000
$30.0 P/Share
|
|
Oct 08
2025
|
Edward M. Md Kaye |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+25.22%
|
$0
$0.6 P/Share
|
|
Oct 03
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
SELL
Open market or private sale
|
Direct |
10,000
-45.81%
|
$250,000
$25.07 P/Share
|
|
Oct 03
2025
|
Jonathan Allan GENERAL COUNSEL & CORP SEC |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+31.42%
|
$90,000
$9.15 P/Share
|
|
Oct 03
2025
|
Edward M. Md Kaye |
SELL
Open market or private sale
|
Direct |
42,461
-46.36%
|
$1,061,525
$25.09 P/Share
|
|
Oct 01
2025
|
Barry Ticho CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,343
-28.93%
|
$122,889
$23.64 P/Share
|